Matches in SemOpenAlex for { <https://semopenalex.org/work/W2555605170> ?p ?o ?g. }
- W2555605170 endingPage "111" @default.
- W2555605170 startingPage "97" @default.
- W2555605170 abstract "HIV-1 infection occurs primarily through mucosal transmission. Application of biologically relevant mucosal models can advance understanding of the functional properties of antibodies that mediate HIV protection, thereby guiding antibody-based vaccine development. Here, we employed a human ex vivo vaginal HIV-1 infection model and a rhesus macaque in vivo intrarectal SHIV challenge model to probe the protective capacity of monoclonal broadly-neutralizing (bnAb) and non-neutralizing Abs (nnAbs) that were functionally modified by isotype switching. For human vaginal explants, we developed a replication-competent, secreted NanoLuc reporter virus system and showed that CD4 binding site bnAbs b12 IgG1 and CH31 IgG1 and IgA2 isoforms potently blocked HIV-1JR-CSF and HIV-1Bal26 infection. However, IgG1 and IgA nnAbs, either alone or together, did not inhibit infection despite the presence of FcR-expressing effector cells in the tissue. In macaques, the CH31 IgG1 and IgA2 isoforms infused before high-dose SHIV challenge were completely to partially protective, respectively, while nnAbs (CH54 IgG1 and CH38 mIgA2) were non-protective. Importantly, in both mucosal models IgG1 isotype bnAbs were more protective than the IgA2 isotypes, attributable in part to greater neutralization activity of the IgG1 variants. These findings underscore the importance of potent bnAb induction as a primary goal of HIV-1 vaccine development." @default.
- W2555605170 created "2016-11-30" @default.
- W2555605170 creator A5002153466 @default.
- W2555605170 creator A5002663565 @default.
- W2555605170 creator A5004036928 @default.
- W2555605170 creator A5005618107 @default.
- W2555605170 creator A5005978177 @default.
- W2555605170 creator A5008989286 @default.
- W2555605170 creator A5009364817 @default.
- W2555605170 creator A5010977815 @default.
- W2555605170 creator A5014091726 @default.
- W2555605170 creator A5016284256 @default.
- W2555605170 creator A5024479924 @default.
- W2555605170 creator A5028344925 @default.
- W2555605170 creator A5029929079 @default.
- W2555605170 creator A5032122826 @default.
- W2555605170 creator A5034536696 @default.
- W2555605170 creator A5036586746 @default.
- W2555605170 creator A5050612131 @default.
- W2555605170 creator A5051827275 @default.
- W2555605170 creator A5055227117 @default.
- W2555605170 creator A5058440042 @default.
- W2555605170 creator A5060698792 @default.
- W2555605170 creator A5062923881 @default.
- W2555605170 creator A5063598326 @default.
- W2555605170 creator A5070100713 @default.
- W2555605170 creator A5070997824 @default.
- W2555605170 creator A5072284822 @default.
- W2555605170 creator A5076272996 @default.
- W2555605170 creator A5084520588 @default.
- W2555605170 date "2016-12-01" @default.
- W2555605170 modified "2023-10-15" @default.
- W2555605170 title "Neutralization Takes Precedence Over IgG or IgA Isotype-related Functions in Mucosal HIV-1 Antibody-mediated Protection" @default.
- W2555605170 cites W1528520360 @default.
- W2555605170 cites W1529809181 @default.
- W2555605170 cites W1533750546 @default.
- W2555605170 cites W1623081601 @default.
- W2555605170 cites W1638160215 @default.
- W2555605170 cites W1656961899 @default.
- W2555605170 cites W1924338894 @default.
- W2555605170 cites W1964828486 @default.
- W2555605170 cites W1965439127 @default.
- W2555605170 cites W1971233211 @default.
- W2555605170 cites W1973208524 @default.
- W2555605170 cites W1974260720 @default.
- W2555605170 cites W1974368619 @default.
- W2555605170 cites W1979058462 @default.
- W2555605170 cites W1984645508 @default.
- W2555605170 cites W1985145726 @default.
- W2555605170 cites W1990745725 @default.
- W2555605170 cites W1992888167 @default.
- W2555605170 cites W1993675648 @default.
- W2555605170 cites W1995466180 @default.
- W2555605170 cites W1995566531 @default.
- W2555605170 cites W2003047948 @default.
- W2555605170 cites W2014071844 @default.
- W2555605170 cites W2017804645 @default.
- W2555605170 cites W2019405644 @default.
- W2555605170 cites W2024287923 @default.
- W2555605170 cites W2026722359 @default.
- W2555605170 cites W2030129290 @default.
- W2555605170 cites W2033043258 @default.
- W2555605170 cites W2038110764 @default.
- W2555605170 cites W2039216085 @default.
- W2555605170 cites W2042074909 @default.
- W2555605170 cites W2052756882 @default.
- W2555605170 cites W2053452332 @default.
- W2555605170 cites W2055057051 @default.
- W2555605170 cites W2060119188 @default.
- W2555605170 cites W2061949672 @default.
- W2555605170 cites W2063195211 @default.
- W2555605170 cites W2063789804 @default.
- W2555605170 cites W2064187617 @default.
- W2555605170 cites W2071959434 @default.
- W2555605170 cites W2074620757 @default.
- W2555605170 cites W2078815165 @default.
- W2555605170 cites W2091294489 @default.
- W2555605170 cites W2093704069 @default.
- W2555605170 cites W2093961711 @default.
- W2555605170 cites W2094258109 @default.
- W2555605170 cites W2095308764 @default.
- W2555605170 cites W2097662686 @default.
- W2555605170 cites W2098013141 @default.
- W2555605170 cites W2102949556 @default.
- W2555605170 cites W2105208620 @default.
- W2555605170 cites W2110233649 @default.
- W2555605170 cites W2113236498 @default.
- W2555605170 cites W2113822425 @default.
- W2555605170 cites W2114288367 @default.
- W2555605170 cites W2128069859 @default.
- W2555605170 cites W2131896393 @default.
- W2555605170 cites W2134269809 @default.
- W2555605170 cites W2135151522 @default.
- W2555605170 cites W2135305016 @default.
- W2555605170 cites W2135847964 @default.
- W2555605170 cites W2137619501 @default.
- W2555605170 cites W2137960793 @default.
- W2555605170 cites W2137990592 @default.